Exosomal microRNAs: impact on cancer detection, treatment, and monitoring
Clinical and Translational Oncology · 06.07.2024 · 27 (1) · 83-94
DOI: 10.1007/s12094-024-03590-6 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical and Translational Oncology, online erschienen am 06.07.2024. Verfasst von Ram Mohan Ram Kumar. Beteiligte Einrichtung: Department of Pharmaceutical Biotechnology, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Mysuru, Karnataka, India. rammohanra…. Hauptthemen laut MEDLINE: Exosomes, Neoplasms, MicroRNAs, Biomarkers, Tumor. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 104 Literaturangaben. Gefördert von: Indian Council of Medical Research.
Abstract (Originalsprache)
Exosomes, measuring between 30 and 150 nm in diameter, are small vesicles enclosed by a lipid bilayer membrane. They are released by various cells in the body and carry a diverse payload of molecules, including proteins, lipids, mRNA, and different RNA species such as long non-coding RNA, circular RNA, and microRNA (miRNA). With lengths of approximately 19-22 nucleotides, miRNAs constitute the predominant cargo in exosomes and serve as crucial regulators of protein biosynthesis. In cancer detection, exosomal miRNAs show promise as non-invasive biomarkers due to their stability and presence in various bodily fluids, aiding in early detection and precise diagnosis with specific miRNA signatures linked to different cancer types. Moreover, exosomal miRNAs influence treatment outcomes by affecting cellular processes like cell growth, cell death, and drug resistance, thereby impacting response to therapy. Additionally, they serve as indicators of disease progression and treatment response, providing insights that can guide treatment decisions and improve patient care. Through longitudinal studies, changes in exosomal miRNA profiles have been observed to correlate with disease progression, metastasis, and response to therapy, highlighting their potential for real-time monitoring of tumor dynamics and treatment efficacy. Understanding the intricate roles of exosomal miRNAs in cancer biology offers opportunities for developing innovative diagnostic tools and therapeutic strategies tailored to individual patients, ultimately advancing precision medicine approaches and improving outcomes for cancer patients. This review aims to provide an understanding of the role of exosomal miRNAs in cancer detection, treatment, and monitoring, shedding light on their potential for revolutionising oncology practices and patient care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Biotechnology, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Mysuru, Karnataka, India. rammohanramkumar@jssuni.edu.in.
Förderung
- Indian Council of Medical Research
Zitieren
APA
Kumar, R. M. R. (2024). Exosomal microRNAs: impact on cancer detection, treatment, and monitoring. Clinical and Translational Oncology, 27(1), 83-94. https://doi.org/10.1007/s12094-024-03590-6
Vancouver
Kumar RMR. Exosomal microRNAs: impact on cancer detection, treatment, and monitoring. Clinical and Translational Oncology. 2024;27(1):83-94. doi:10.1007/s12094-024-03590-6
BibTeX
@article{Kumar2024,
author = {Kumar, Ram Mohan Ram},
title = {Exosomal microRNAs: impact on cancer detection, treatment, and monitoring},
journal = {Clinical and Translational Oncology},
year = {2024},
volume = {27},
number = {1},
pages = {83--94},
doi = {10.1007/s12094-024-03590-6}
}
EUVIMED